The next round of tests and appointments will be in April, so we will update the blog after that round.
Thank you for your continued prayers and support!
The Lantz Family
#carolinestrong
#ftgf
Fresh batch of DFMO!
Parent view of the CT Scan
In 2017, Caroline was diagnosed with Stage IV, High-Risk Neuroblastoma: an aggressive, solid-tumor cancer that spread throughout almost all of her body, including her bone marrow. She completed a 2-year clinical trial (called DFMO) in April 2021, and relapsed in April 2022. She is currently a patient at the Monroe Carell Jr. Children's Hospital at Vanderbilt in Nashville, TN; this blog documents her journey.
Wednesday, December 2, 2020
CT Scan Results
Caroline had her follow-up CT scan today, and the results where all good! The scan showed no issues with the spot that appeared on her liver during her October scans. She remains NED (no evidence of disease) and will continue taking the clinical trial drug, DFMO, until April 2021.
Subscribe to:
Posts (Atom)